PASTEUR MERIEUX SEEKS TO KEEP CONNAUGHT RABIES VACCINE BUSINESS
PASTEUR MERIEUX SEEKS TO KEEP CONNAUGHT RABIES VACCINE BUSINESS by asking the Federal Trade Commission to override an order obligating the company to lease out the business as a condition of Merieux' purchase of Connaught in 1989. In a petition filed with the FTC Dec. 23, Pasteur Merieux maintains that despite a three-year search, no suitable lessee has been found, and, in the interim, new suppliers of rabies vaccine have emerged in the U.S. The petition is subject to public comment through Jan. 31.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth